Intel plans to start dispatching its 10nm processors by June this year

Future Intel Core i7 quad-core chips may have twice the graphics performance over its 8th-generation counterpart and up to three times the AI capabilities Intel, the US semiconductor giant, has recently confirmed that its 10-nanometer proc....

Porsche fined €535m by German prosecutors over diesel emissions fraud

Audi, VW, Porsche all sold diesel engine vehicles that had failed to meet clean air regulations and were able to cheat emissions tests Reports suggest that prosecutors in Germany have levied a 535 million euro fine on German luxury automob....

Proofpoint Inc. to acquire Meta Networks Ltd. for $120 million

The employees of Mata Networks will join Israeli team of Proofpoint after the acquisition. The U.S. based enterprise security company Proofpoint Inc. has reportedly announced that it has signed an agreement to acquire Meta Networks Ltd., ....

Pfizer obtains FDA approval for oral heart drug costing $225K a year

In May the drug received FDA breakthrough status and had lowered the risk of death for patients by 30% as compared to placebo The U.S. Food and Drug Administration has recently approved tafamidis, an oral drug from Pfizer Inc for treating ....

Cytokinetics declares FORTITUDE-ALS results from reldesemtiv study

FORTITUDE-ALS did not attain statistical importance in its primary endpoint of change from baseline in SVC Patients who received reldesemtiv in FORTITUDE-ALS exhibited lesser decline than the patients who received placebo Cytokinetics has....

Context Therapeutics begins Phase 2 Apristor trial for cancer patients

The latest study will assess Apristor’s safety plus pharmacological profile in patients, besides the biomarker analyses, for exploring the drug’s predictive response factors. Context Therapeutics, a U.S.-based clinical stage bi....

Audentes exhibits new positive data from the ASPIRO clinical trial

The leading American AAV-based genetic medicines company, Audentes Therapeutics Inc., has reportedly presented new positive data from ASPIRO, the AT132 Phase 1/2 clinical trial for the treatment of XLMTM (X-linked Myotubular Myopathy). The ....

Norton Healthcare & Select Medical tie up on outpatient rehabilitation

In a recent turn of events, Norton Healthcare and Select Medical have reportedly declared signing a joint venture agreement intended to assimilate outpatient rehabilitation solutions in the Southern Indiana and Louisville metro provinces.&n....

Renault to plan a joint holding company with Japanese carmaker Nissan

Renault, the French multinational automobile manufacturer, has reportedly announced that it is aims to propose a plan for creating a joint holding company with Japanese multinational carmaker Nissan, which is likely to provide both the comp....

Supermicro breaks ground for new facility spanning 800,000 square feet

San Jose-based IT company Super Micro Computer, Inc., has made it to the headlines for officially inaugurating its all-new new 800,000-square foot establishment in Taiwan. The firm, in conjunction, is also further expanding its headquarters....